Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Renal Cell 4Lymphoma, Mantle-Cell 2Carcinoma 2Carcinoma, Squamous Cell 1

Interventions

Blood Specimen Collection 5Therapeutics 2Surveys and Questionnaires 2Cetuximab 2temsirolimus 1Tumor Burden 1Spectrum Analysis, Raman 1Risedronic Acid 1Raloxifene Hydrochloride 1Radiotherapy, Intensity-Modulated 1Radiomics 1Radiation, Ionizing 1Quality of Life 1Phlebotomy 1Neck Dissection 1Mohs Surgery 1Microscopy, Confocal 1Interviews as Topic 1Immunotherapy 1Ibandronic Acid 1Histocompatibility Testing 1Etidronic Acid 1Esophagectomy 1Dermoscopy 1Carboxylesterase 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Carcinoma, Squamous Cell × temsirolimus × Clear all
NCT00195299 2007-12-27

Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck

Wyeth is now a wholly owned subsidiary of Pfizer

Completed
20 enrolled
Tumor-Agnostic

Carcinoma, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡